A 30-year-old HIV-positive patient on tenofovir alafenamide (TAF)-based regimen is switched from tenofovir disoproxil fumarate (TDF) due to declining eGFR. What is the pharmacokinetic rationale for TAF's improved renal and bone safety compared to TDF?

• A TAF is a smaller molecule with lower renal clearance and does not accumulate in proximal tubular cells
• B TAF is directly nephroprotective by blocking organic anion transporters in the kidney that mediate cisplatin nephrotoxicity
• C TAF is a prodrug that converts intracellularly to the active tenofovir diphosphate; it is more efficiently taken up by lymphocytes (HIV reservoir) and undergoes plasma hydrolysis to produce much lower systemic tenofovir concentrations, reducing renal proximal tubule and bone exposure compared to TDF ✓
• D TAF bypasses first-pass metabolism completely and reaches renal tissue without generating toxic metabolites that TDF produces via oxidative metabolism

Explanation

Both TDF and TAF are prodrugs of tenofovir (nucleotide reverse transcriptase inhibitor). TDF is rapidly converted in plasma to tenofovir, resulting in high plasma tenofovir concentrations that are renally filtered and actively secreted, leading to high proximal tubular cell concentrations and dose-dependent nephrotoxicity (Fanconi syndrome, tubulopathy, declining eGFR) and bone mineral density loss (via proximal tubule phosphate wasting). TAF is a more stable prodrug that is not converted significantly in plasma — it is taken up intact by CD4+ T lymphocytes (and macrophages) where it is converted by cathepsin A to the active tenofovir diphosphate intracellularly. This cell-targeted delivery results in 90% lower plasma tenofovir concentrations compared to TDF at equivalent intracellular efficacy, dramatically reducing renal and bone exposure. TAF requires only 25 mg versus TDF's 300 mg due to this efficiency.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.